Inventor · disambiguated record
Luke Whitesell
Also filed as: WHITESELL LUKE · WHITESELL LUKE J
6 granted patents·5 pending applications·35 citations·filing 1994–2020
77Inventor score
Files withWHITEHEAD INST BIOMEDICAL RES5GUNATILAKA LESLIE1MASSACHUSETTS INST TECHNOLOGY1UNIV BOSTON1US HEALTH1
Top patents by PatentIndex Score
11 records- 0186US9738610B2Indazole derivatives and uses thereofWHITEHEAD INST BIOMEDICAL RES·Filed 2013·Granted Aug 22, 2017·7 cites·19 claims
- 0280US9944607B2Thiohydantoin derivatives and uses thereofWHITEHEAD INST BIOMEDICAL RES·Filed 2013·Granted Apr 17, 2018·3 cites·16 claims
- 0377US9505735B2Compounds for treating infectious diseasesWHITEHEAD INST BIOMEDICAL RES·Filed 2013·Granted Nov 29, 2016·3 cites·38 claims
- 0465US6040334AUse of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapyUS HEALTH·Filed 1994·Granted Mar 21, 2000·22 cites·5 claims
- 0547US2011230551A1Withaferin a analogs and uses thereofGUNATILAKA LESLIE·Filed 2009·Application pending·0 cites
- 0645US2019365719A1Combination treatments of hsp90 inhibitors for enhancing tumor immunogenicity and methods of use thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Application pending·0 cites
- 0743US11312722B2Hsp90 inhibitors and uses thereofUNIV BOSTON·Filed 2020·Granted Apr 26, 2022·0 cites·31 claims
- 0840US2015241436A1Hsf1 and hsf1 cancer signature set genes and uses relating theretoWHITEHEAD BIOMEDICAL INST·Filed 2013·Application pending·0 cites
- 0937US9696313B2HSF1 as a marker in tumor prognosis and treatmentWHITEHEAD INST FOR BIO-MEDICAL RES·Filed 2012·Granted Jul 4, 2017·0 cites·17 claims
- 1035US2017066797A1Withaferin a analogs and uses thereofWHITEHEAD INST BIOMEDICAL RES·Filed 2016·Application pending·0 cites
- 1131US2017037480A1Hsf1 in tumor stromaWHITEHEAD INST BIOMEDICAL RES·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Luke Whitesell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →